Loading...
Innovative Eyewear, Inc.
LUCY•NASDAQ
Healthcare
Medical - Instruments & Supplies
$2.13
$0.04(1.91%)
Innovative Eyewear, Inc. (LUCY) Financial Performance & Income Statement Overview
Review Innovative Eyewear, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
141893.04%
↑ 141893.04%
Operating Income Growth
-34263.62%
↓ 34263.62%
Net Income Growth
-116454.35%
↓ 116454.35%
Operating Cash Flow Growth
-116779.57%
↓ 116779.57%
Operating Margin
-65.80%
↓ 65.80%
Gross Margin
48.43%
↑ 48.43%
Net Profit Margin
-391.55%
↓ 391.55%
ROE
-94.90%
↓ 94.90%
ROIC
-4.00%
↓ 4.002%
Innovative Eyewear, Inc. (LUCY) Income Statement & Financial Overview
Review Innovative Eyewear, Inc.'s (LUCY) income statement with detailed quarterly and annual figures.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $253599.00 | $308682.00 | $383471.00 | $615754.00 |
| Cost of Revenue | $194255.00 | $253506.00 | $376520.00 | $795902.00 |
| Gross Profit | $59344.00 | $55176.00 | $6951.00 | -$180148.00 |
| Gross Profit Ratio | $0.23 | $0.18 | $0.02 | -$0.29 |
| R&D Expenses | $131369.00 | $256802.00 | $216301.00 | $120836.00 |
| SG&A Expenses | $1.66M | $1.74M | $447651.00 | $2.19M |
| Operating Expenses | $59344.00 | $2.03M | $663952.00 | $2.32M |
| Total Costs & Expenses | $253599.00 | $2.28M | $1.04M | $3.11M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $33858.00 | $45775.00 | $29473.00 | $19231.00 |
| EBITDA | -$1.69M | -$1.90M | -$1.94M | -$2.37M |
| EBITDA Ratio | -$6.65 | -$6.16 | -$1.71 | -$4.02 |
| Operating Income | -$1.76M | $0.00 | -$657001.00 | -$2.50M |
| Operating Income Ratio | -$6.95 | $0.00 | -$1.71 | -$4.05 |
| Other Income/Expenses (Net) | $41386.00 | -$1.95M | $43279.00 | $146797.00 |
| Income Before Tax | -$1.72M | -$1.95M | -$1.97M | -$2.39M |
| Income Before Tax Ratio | -$6.79 | -$6.31 | -$5.14 | -$3.89 |
| Income Tax Expense | $1.72B | $0.00 | -$29473.00 | -$1.00 |
| Net Income | -$1.72B | -$1.95M | -$1.97M | -$2.39M |
| Net Income Ratio | -$6785.03 | -$6.31 | -$5.14 | -$3.89 |
| EPS | -$990.72 | -$1.87 | -$3.04 | -$3.70 |
| Diluted EPS | -$990.72 | -$1.87 | -$3.04 | -$3.70 |
| Weighted Avg Shares Outstanding | $1.74M | $1.04M | $647605.00 | $647441.00 |
| Weighted Avg Shares Outstanding (Diluted) | $1.74M | $1.04M | $647605.00 | $647441.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan